Status:
WITHDRAWN
Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients
Lead Sponsor:
Mclean Hospital
Conditions:
Depression, Anxiety
Eligibility:
All Genders
50-89 years
Brief Summary
This is an observational study evaluating the safety and efficacy of dronabinol for the treatment of anxiety and/or depression in older adults. Participants who are prescribed dronabinol as part of a ...
Detailed Description
Recently there has been renewed interest in potential alternative medical applications of cannabis/THC and medical marijuana is now legalized in 23 states and the District of Columbia. Acute effects o...
Eligibility Criteria
Inclusion
- 50-89 years old (inclusive)
- Inpatient on the Older Adult Unit in South Belknap 1 at McLean Hospital
- Initiating dronabinol therapy for the treatment of any Diagnostic and Statistical Manual (DSM) 5 Major Depression or Anxiety Disorder Diagnosis
- Ability to provide informed consent
- Must be fluent in English
Exclusion
- Delirium as determined by the Confusion Assessment Method (CAM)
- Serious or unstable medical illness, including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease, which might confound assessment of safety outcomes
- Seizure disorder
- Diagnosis of bipolar depression, Major depression with psychotic features, schizophrenia, schizoaffective disorder, dementia
- Use of dronabinol or marijuana in the last year
- Prescription of lithium or anticonvulsant medications (except gabapentin)
- Patient currently admitted involuntarily to McLean Hospital
Key Trial Info
Start Date :
November 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03369639
Start Date
November 28 2017
End Date
October 1 2018
Last Update
July 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478